140 related articles for article (PubMed ID: 3523341)
1. [Tumor markers in the diagnosis of ascitic and pleural puncture fluids].
Mezger J; Lamerz R; Arnholdt H; Huhn D; Wilmanns W
Onkologie; 1986 Feb; 9(1):11-6. PubMed ID: 3523341
[TBL] [Abstract][Full Text] [Related]
2. Tumour associated antigens in diagnosis of serous effusions.
Mezger J; Permanetter W; Gerbes AL; Wilmanns W; Lamerz R
J Clin Pathol; 1988 Jun; 41(6):633-43. PubMed ID: 2454957
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of various tumor markers in pleural effusion and in the serum].
Jibiki K; Abe Y; Takeda M; Iwachika C; Odagiri E; Demura R; Demura H
Gan No Rinsho; 1989 Aug; 35(9):991-8. PubMed ID: 2769951
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of cancer antigen 15-3 (CA15-3) detected by monoclonal antibodies (115D8 and DF3) in exudative pleural effusions.
Shimokata K; Totani Y; Nakanishi K; Yamamoto M; Hasegawa Y; Kawatsu H; Sasou H; Murate T; Ichiyama S; Kurasawa T
Eur Respir J; 1988 Apr; 1(4):341-4. PubMed ID: 3165069
[TBL] [Abstract][Full Text] [Related]
5. Carcinomatous and tuberculous pleural effusions. Comparison of tumor markers.
Niwa Y; Kishimoto H; Shimokata K
Chest; 1985 Mar; 87(3):351-5. PubMed ID: 3971760
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of three tumor markers determined in pleural effusions.
Conejo JR; Benedito JE; Jimenez A; Menchen M; Cano J; Granizo V; Larrodera L
Eur J Clin Chem Clin Biochem; 1996 Feb; 34(2):139-42. PubMed ID: 8833646
[TBL] [Abstract][Full Text] [Related]
7. P53-immunoreactive cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-staining.
Stoetzer OJ; Munker R; Darsow M; Wilmanns W
Oncol Rep; 1999; 6(2):455-8. PubMed ID: 10023021
[TBL] [Abstract][Full Text] [Related]
8. Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen.
Mezger J; Stötzer O; Schilli G; Bauer S; Wilmanns W
Acta Cytol; 1992; 36(1):75-81. PubMed ID: 1546516
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies in the cytodiagnosis of serous effusions.
al-Nafussi A; Carder PJ
Cytopathology; 1990; 1(2):119-28. PubMed ID: 1714782
[TBL] [Abstract][Full Text] [Related]
10. [Differential cytology of effusions using monoclonal antibodies].
Lüttges J; Neumann K; Pflüger KH; Schmitz-Moormann P
Pathologe; 1988 May; 9(3):137-42. PubMed ID: 2457213
[No Abstract] [Full Text] [Related]
11. Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
Salama G; Miédougé M; Rouzaud P; Mauduyt MA; Pujazon MC; Vincent C; Carles P; Serre G
Br J Cancer; 1998; 77(3):472-6. PubMed ID: 9472646
[TBL] [Abstract][Full Text] [Related]
12. [The immunocytochemical study of pleural effusion and ascites using Ber-EP-4 antibodies].
Spehn J; Iwanetz S; Schmitz-Huebner U
Dtsch Med Wochenschr; 1995 Sep; 120(36):1197-200. PubMed ID: 7671771
[TBL] [Abstract][Full Text] [Related]
13. [The diagnostic value of carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA) in pleural effusion].
Chen TM; Chang SC; Lu JY; Perng RP
Zhonghua Yi Xue Za Zhi (Taipei); 1987 Oct; 40(4):375-82. PubMed ID: 3502856
[No Abstract] [Full Text] [Related]
14. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
15. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry.
Tickman RJ; Cohen C; Varma VA; Fekete PS; DeRose PB
Acta Cytol; 1990; 34(4):491-6. PubMed ID: 2197840
[TBL] [Abstract][Full Text] [Related]
16. [Carcinoembryonic and tissue polypeptide antigens in the diagnosis of malignant serous effusions].
Pérez Miranda E; Juárez Fernández C; Mayorga Torreblanca E; Paredes Castillo G; Cotrina de Luna JL; Causse Prado M
Rev Clin Esp; 1986 Jun; 179(1):12-7. PubMed ID: 3738042
[No Abstract] [Full Text] [Related]
17. Clinical evaluation of the simultaneous determination of tumor markers in fluid and serum and their ratio in the differential diagnosis of serous effusions.
Trapé J; Molina R; Sant F
Tumour Biol; 2004; 25(5-6):276-81. PubMed ID: 15627892
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic interest of the monoclonal antibody CA1 in malignant pleural effusion.
Font P; Palacìn A; Font J; Faus R; Molina R; Ballesta AM; Cardesa A; Ingelmo M
Int J Biol Markers; 1987; 2(3):157-60. PubMed ID: 2453591
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated antigens in effusions of malignant and benign origin.
Ammon A; Eiffert H; Reil S; Beyer JH; Droese M; Hiddemann W
Clin Investig; 1993 Jun; 71(6):437-44. PubMed ID: 8353402
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies.
Ghosh AK; Spriggs AI; Taylor-Papadimitriou J; Mason DY
J Clin Pathol; 1983 Oct; 36(10):1154-64. PubMed ID: 6194183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
